Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes

References

• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Facts and figures: did you know? www.idf.org/home/index.cfm?node=6 (last accessed November, 2004)
   Google Scholar
• The DCCT Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995;47:1703–20
   PubMed Web of Science ®Google Scholar
• Anon. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. J Am Med Assoc 2002;287:2563–9
   Web of Science ®Google Scholar
• UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703–13
   PubMed Web of Science ®Google Scholar
• Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17
   PubMed Web of Science ®Google Scholar
• Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004;291:335–42
   Google Scholar
• Koro CE, Bowlin SJ, Bourgeois N, et al. Glycaemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27:17–20
   PubMed Web of Science ®Google Scholar
• Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, et al. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 2003;18: 793–800
   Google Scholar
• Gatling W, Budd S, Walters D, et al. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabetic Med 1998;15:1015–21
   PubMed Web of Science ®Google Scholar
• Berger B, Stenstrom G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 1999;22:773–8
   Google Scholar
• Sarol Jr JN, Nicodemus Jr NA, Tan KM, et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005;21:173–84
   PubMed Web of Science ®Google Scholar
• Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005;2:CD005060
   Google Scholar
• Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28: 1510–7
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Gavin III JR. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005;118(Suppl 9A):1S–6S
   Google Scholar
• Standards of medical care in diabetes. Diabetes Care 2004;27(Suppl 1):S15–S35
   Google Scholar
• American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus [report published in 2002]
   Google Scholar
• Mayfield J, Havas S; for the AAFP Panel on Self-Monitoring of Blood Glucose. Self-control: a physician’s guide to blood glucose control monitoring in the management of diabetes. An American Family Physician Monograph. www.aafp.org/x25813.xml (last accessed February 2005)
   Google Scholar
• Canadian Diabetes Association. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27(Suppl 2): S1–S152
   Google Scholar
• Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002;25:1933–9
   PubMed Web of Science ®Google Scholar
• Anon. Follow-up of the type 2 diabetic patient excluding follow-up of complications. [Recommendations of ANAES]. Diabetes Metab 1999;25(Suppl 2):1–64
   Google Scholar
• Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1–9
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (Types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004;20(Suppl 1):S5–S26
   PubMedGoogle Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE diabetes model against epidemiological and clinical studies. Curr Med Res Opin 2004;20(Suppl 1):S27–S40
   PubMedGoogle Scholar
• Hermansen K, Fontaine P, Kukolja KK, et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes. Diabetologia 2004;47:622–9
   PubMed Web of Science ®Google Scholar
• Primatesta P, Poulter NR. Lipid levels and the use of lipid-lowering agents in England and Scotland. Eur J Cardiovasc Prev Rehabil 2004;11:484–8
   PubMed Web of Science ®Google Scholar
• Wilson A, Baker R, Thompson J, et al. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. Diabetic Med 2004;21:271–8
   PubMed Web of Science ®Google Scholar
• Benett IJ, Lambert C, Hinds G, et al. Emerging standards for diabetes care from a city-wide primary care audit. Diabetic Med 1994;11:489–92
   PubMed Web of Science ®Google Scholar
• Valentine WJ, Palmer AJ, Lammert M, et al. Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting. Curr Med Res Opin 2005;21:2063–71
   PubMed Web of Science ®Google Scholar
• Coster S, Gulliford MC, Seed PT, et al., editors. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess 2000;4(12)
   Google Scholar
• Albisser AM, Sakkal S, Wright C. Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes. Diabetes Technol Ther 2005;7:487–96
   Google Scholar
• Kovatchev BP, Cox DJ, Kumar A, et al. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 2003;5:817–28
   PubMedGoogle Scholar
• Murata GH, Shah JH, Hoffman RM, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003;26:1759–63
   PubMed Web of Science ®Google Scholar
• Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004;30:112–25
   Google Scholar
• Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in Type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28:260–5
   PubMed Web of Science ®Google Scholar
• Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Med 2003;20:442–50
   PubMed Web of Science ®Google Scholar
• Department of Health. NHS Reference Costs 2003 and National Tariff 2004. =http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4070195&chk=UzhHA3 (last accessed April 2004)
   Google Scholar
• Netten A, Curtis L. Unit costs of health and social care 2003. http://www.pssru.ac.uk/pdf/uc2003/uc2003_inflation.pdf (last accessed November 2005)
   Google Scholar
• Grieve R, Beech R, Vincent J, et al. Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Assess 1999;3(15)
   Google Scholar
• Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) [United Kingdom Prospective Diabetes Study Group]. Br Med J 2000;320:1373–8
   PubMed Web of Science ®Google Scholar
• Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25: 1928–32
   Google Scholar
• Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994;31: 215–9
   Google Scholar
• Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238–43
   PubMed Web of Science ®Google Scholar
• Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327–40
   Google Scholar
• Smith TJ, Hillner BE, Schmitz N, et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin’s and non-Hodgkin’s lymphoma. J Clin Oncol 1997;15:5–10
   PubMed Web of Science ®Google Scholar
• Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 2004;13:437–52
   PubMed Web of Science ®Google Scholar
• Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Kleefstra et al. and Davidson. Diabetes Care 2005;28:2597a–2598a
   Google Scholar
• Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587–94
   PubMed Web of Science ®Google Scholar
• Franciosi M, Pellegrini F, De Berardis G, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24:1870–7
   PubMed Web of Science ®Google Scholar
• Schiel R, Muller UA, Rauchfub J, et al. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group. Diabetes Metab 1999;25:334–40
   PubMed Web of Science ®Google Scholar